Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Trading Statement

13 Apr 2011 07:00

RNS Number : 7990E
Flying Brands Limited
13 April 2011
 



13 April 2011

 

FLYING BRANDS LIMITED

 

Trading Update

 

Since our preliminary results announcement the business has continued to operate against the backdrop of an increasingly challenging consumer environment and increasing competition in its key markets. Overall Group orders for the period to 1 April 2011 of £10.8m (£2010: £10.7m) are marginally ahead of the same period last year. On a like for like basis, excluding those businesses we acquired in 2010, orders are 19.8% below last year.

 

Overall we believe that our strategy for transforming our business remains the right one but the continuing under-performance in the traditional flowers business and the recent decline in our bird food business means that profits for this year will be materially below market expectations. We will need to renegotiate the terms of our banking arrangements and we will be commencing discussions with our lenders very shortly.

 

 

Flowers & Gifts

The performance of our Flowers and Gifts Division over the important first quarter was materially below our expectations in what is currently our main direct-to-consumer (DTC) business. Orders to 1 April 2011 were £3.4m (2010: £2.3m); this includes first time contributions from Flowers Direct and Drake Algar. Like for like orders were 14.7% below last year. Our DTC businesses have been impacted, like many retailers, by weak consumer confidence. We have also experienced increasing competition from general retailers and more discounting from other specialist flower companies. Mothers Day trading in the three weeks prior to that event was particularly difficult with sales materially below our expectations.

 

The performance of the relay network is improving and we expect to conclude at least one large third party deal in the near future.

 

We are accelerating our plans to increase the emphasis on our relay network, on retail partnerships and corporate business, which we believe will transform the prospects for our flowers and gifts division.

 

In the short-term our new initiatives will not be enough to offset the decline in our traditional DTC business as we transition to this new business model.

 

 

Garden

Our Garden Division has had a mixed start to the year. Our bird food business has seen very challenging trading conditions with a marked increase in competition from low cost providers such as the supermarkets and garden centres and an increase in the number of entrants to the online market. Orders to 1 April at £0.8m are 33.5% down on last year. Profits for the year-to-date are materially below our expectations and we do not expect trading conditions to improve markedly in the short-term.

 

Gardening Direct orders at 1 April are £5.5m (2010:£6.4m).

 

The business had a challenging March with sales materially below expectations but April has started well. It remains to be seen whether we can claw back at least some of that under-performance. We reduced our marketing expenditure in off the page advertising during the first quarter to reflect the lower demand but are monitoring the market to make sure we take advantage of any perceived upturn. We do not now expect the financial performance of the business in the first half of the year to be better than last year.

 

We recently improved our site at www.gardencentreonline.co.uk and are planning a major re-launch of this brand when these improvements are completed and fully bedded down. Even prior to that re-launch sales are now regularly ahead of last year and we are pleased that this business is trading in line with our expectations in an increasingly challenging consumer environment. We expect www.gardencentreonline.co.uk to be an increasingly important part of our business in future.

 

 

Dealtastic

Our new Dealtastic site is still in its early stages. The functionality and features on this "deal of the day" site continue to improve from week to week and we are starting to see increased traffic to that site although we have not yet seen a significant increase in weekly sales.

 

 

For further information, please contact:

 

Flying Brands Limited 01245 228 300

Stephen Cook, Chief Executive

Anthony Gee, Finance Director

 

Smithfield Consultants 020 7360 4900John Kiely

 

Notes to editors

 

Jersey based Flying Brands Limited (LSE: FBDU) is a multi brand and multi channel home shopping specialist. Founded in 1981, it was admitted to the Official List of the London Stock Exchange in 1993. The Group operates the following divisions: 

 

·; Gifts (Flying Flowers, Flowers Direct and Drake Algar  making the company one of the UK'sleading florists)

·; Garden (Gardening Direct, one of the UK's largest mail order bedding plants and gardening products operations; Garden Bird Supplies, a leading provider of food and accessories for birds and other wildlife; Garden Centre Online, an internet retailer of garden hardware products)

·; Entertainment (Listen2, a mail order audio books, nostalgic music, DVD and video home shopping retailer)

·; Dealtastic (Deal a day website)

More information can be found at: www.flyingbrands.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVDSIIFLIL
Date   Source Headline
18th Aug 202311:20 amRNSIB & GE HealthCare Enter into Commercial Agreement
17th Aug 20237:00 amRNSHalf-year Report
19th Jul 20237:00 amRNSImaging Biometrics Installs IB Nimble™ For MCW
13th Jul 20237:00 amRNSOrphan Drug Designation for GaM in Pediatric GBM
27th Jun 20237:00 amRNSStudies Show GaM Inhibits Pediatric Tumor Growth
23rd May 202311:02 amRNSResult of AGM
23rd May 20237:00 amRNSAGM Statement
3rd May 20234:14 pmRNSNotice of AGM
26th Apr 20237:00 amRNSFinal Results
28th Feb 20233:52 pmRNSOrphan Drug Designation Status
13th Jan 20232:05 pmRNSSecond Price Monitoring Extn
13th Jan 20232:00 pmRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSLetter to Shareholders
2nd Dec 202211:11 amRNSHolding in Company
25th Oct 202211:00 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSLetter to Shareholders
26th Sep 20227:00 amRNSIssue of Warrants to Employees
16th Aug 20224:40 pmRNSSecond Price Monitoring Extn
16th Aug 20224:35 pmRNSPrice Monitoring Extension
16th Aug 20229:28 amRNSHalf-year Report
3rd Aug 20221:01 pmRNSTR1 - Notification of Major Holdings
11th Jul 20227:00 amRNSImaging Biometrics Announces Channel Partnership
31st May 202211:05 amRNSSecond Price Monitoring Extn
31st May 202211:00 amRNSPrice Monitoring Extension
31st May 20228:00 amRNSSubmission of FDA 510(k) Application for IB Zero G
30th May 202210:47 amRNSResult of AGM
5th May 20223:00 pmRNSNotice of AGM
3rd May 20222:21 pmRNSIB Broadens Quantitative Mapping
28th Apr 20225:52 pmRNSFinal Results
9th Mar 20223:08 pmRNSIQAI’s Sponsored Phase I Clinical Trial is Open
28th Feb 202211:12 amRNSTotal Voting Rights
8th Feb 20227:00 amRNSIssue of shares to Mayo Clinic
27th Jan 20227:00 amRNSImaging Biometrics LLC - Letter to Shareholders
4th Jan 20229:27 amRNSDirector/PDMR Shareholding
17th Dec 20217:37 amRNSIQ-AI Prepares for Phase I Clinical Trial Launch
13th Dec 202110:32 amRNSDirector's Interest
11th Nov 20218:52 amRNSAgreement with St. Jude Children’s Hospital
2nd Nov 20218:19 amRNSMD ANDERSON ADOPTS IB CLINIC
28th Oct 20214:00 pmRNSLetter to Shareholders
7th Oct 20214:41 pmRNSSecond Price Monitoring Extn
7th Oct 20214:36 pmRNSPrice Monitoring Extension
7th Oct 20212:05 pmRNSSecond Price Monitoring Extn
7th Oct 20212:00 pmRNSPrice Monitoring Extension
7th Oct 202112:00 pmRNSPlacing
1st Oct 20218:17 amRNSCase Report on Clinical Value of IB Software
22nd Sep 20217:00 amRNSEU PATENT FOR DUAL-ECHO MR PERFUSION PROCESSSING
17th Sep 20217:00 amRNSIB Software Chosen for Accuracy and Automation
10th Sep 20217:00 amRNSUpdate on Phase I Clinical Trial

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.